Loxoprofen

This classification denotes a cyclooxygenase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3583H0GZAP. European Medicines Agency schedules Loxoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08609MIG. Loxoprofen generally arises in the molecular formula C15H18O3. The term LOXOPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) LOXOPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule loxoprofen under HS 29183000 and SITC 51395. As of Q4 2014, LOXOPROFEN remains the US FDA Preferred Term for this commodity. Loxoprofen bears US NLM identifiers UMLS ID C0065199 and NCI Concept Code C81064. SMILES: O=C1C(CCC1)CC1CCC(CC1)C(C)C(=O)O.